Opportunity knocks for software makers




OK, software makers, you're up.

Drug developers need capacity-planning solutions--really good ones that account for resource costs (see related story). And they have to be up to the challenges of increasingly complex clinical trial protocols, including those for adaptive trials, and accurate enough to show cost savings.

Yes, you've provided clinical capacity-planning features within trial management solutions. But now it's time to step it up a notch, says Kenneth Kaitin of the Tufts Center for the Study of Drug Development.

The need is now for capacity-planning solutions based on an accurate understanding of resource costs. Here's your chance to shine.

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.